Rob C. Hoeben
Leiden, ZH 2333ZA, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Improved oncolytic and immunostimulatory activity of the spontaneous jin-3 reovirus mutant in preclinical bladder cancer models.
Journal: Molecular therapy. Oncology
Published: August 18, 2025
Selector adeno-associated viral vectors facilitate on-target precise genome editing and purge off-target chromosomal insertions.
Journal: Trends in biotechnology
Published: June 23, 2025
Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomas.
Journal: Molecular therapy. Oncology
Published: June 23, 2025
A new adenovirus isolated from a western lowland gorilla held in captivity.
Journal: Virology
Published: May 21, 2025
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas.
Journal: International journal of molecular sciences
Published: December 18, 2024
Immune Shielding of Human Heart Valves: A Proof-of-Concept Study of HLA-Targeting Therapy for Transplantations.
Journal: JACC. Basic to translational science
Published: May 01, 2024
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles.
Journal: Molecular therapy. Oncology
Published: October 11, 2023
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.
Journal: Cancer immunology research
Published: June 08, 2023
Last Updated: 09/26/2026